Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine in Angioimmunoblastic T-Cell Lymphoma
NCT00070291Phase 2Terminated
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jan 2006
- Primary completion
- Mar 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in angioimmunoblastic T-cell lymphoma (AITL), sponsored by Eastern Cooperative Oncology Group. Started Jan 2006; status: terminated.
02
Drugs
cyclosporine
03
Conditions
angioimmunoblastic T-cell lymphoma (AITL)
Beyond the preview
Go deeper on NCT00070291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070291.